Low levels of DDX3X expression have been associated with poor prognosis in patients with colorectal cancer [160] and in patients who are non-smokers with oral cancer [162], while a high expression of DDX3X is associated with poor prognosis in gliomas [163]. This evidence concerns the gene DDX3X and central nervous system cancer.